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Summary.
It is well known that the Atrial Natriuretic Peptide (ANP) plays a major role in vasorelaxation and in lowering systolic blood pressure. However, little information is available concerning its effect on the autonomic outflows.
The present study deals with the effect of rat ANP (rANP) on the efferent activity of the sympathetic and vagal outflows.
Under anesthesia (urethane 700mg/kg and chrolarose 50 mg/kg, intraperitoneal), the effect of intravenous administration of rANP was observed in rats. A suppression of the efferent activity was recognized after administration of rANP in adrenal, renal and splenic sympathetic nerve fibers, and also in vagal gastric, pancreatic and hepatic nerve fibers. The smallest effective dose was 100pg.
In decerebrated preparations no change in efferent activity after administration of rANP was recognizable.
The results indicate that rANP released from the atrium to systemic circulation modulates autonomic outflows through the hypothalamic neurons surrounded by an insufficient blood brain barrier.
Atrial natriuretic polypeptide (ANP) has received much attention since descriptions of experiments (DE BOLD et al., 1981; JAMIESON and PALADE, 1964) showing that the intravenous administration of rat atrial extracts, but not ventricular extracts, causes a large and prompt natriuresis and diuresis. Subsequently, ANP has been purified, sequenced, and synthesized (DE BOLD and FLYNN, 1983; FLYNN et al., 1983; GRAMMER et al., 1983; ATLAS et al., 1984; SUGIYAMA et al., 1984; KANGAWA and MATSUO, 1984) , and the action of this peptide has been shown to include blood pressure lowering effects in both anesthetized (DE BOLD et al., 1981; CURRIE et al., 1983; WINQUIST et al., 1984) and conscious (HINTZE et al., 1985; GOETZ et al., 1986) animals as well as an inhibitory effect on reninangiotensin and aldosterone secretion (ATARASHI et al., 1984; BURNETT et al., 1984; MAACK et al., 1984; VOLPE et al., 1985) . In relation to the blod pressure lowering effect of ANP, THEOREN et al. (1986) observed the suppression of the renal sympathetic activity after intravenous administrations of this substance in the rat. In these experiments most investigators have used relatively large doses when determining the action of this substance.
Outside of THEOREN's report, little information is available on the effect of ANP on the autonomic outflows, although it is possible to assume that the change in autonomic outflows plays a role in lowering the blood pressure and natriuresis by the administration of ANP. Further, it is probable that ANP not only affects the activity of the renal eff erents but also modulates the efferent activity of the autonomic outflows in general. Against this point of view, we planned a series of experiments to investigate the effect of ANP on sympathetic outflows-in the kidney, adrenal, pancreas, liver, spleen and brown adipose tissue, and vagal outflows of the stomach, pancreas and liver. This paper constitutes a preliminary report on the effects of ANP on the efferent activities of adrenal, renal, splenic sympathetic nerves, and those of vagal gastric, hepatic and pancreatic nerves in the rat.
METHODS
Male Wistar rats (350-400g) were anesthetized with an intraperitonal injection of a mixture of urethane (700mg/kg) and a-chloralose (70mg/kg). The inferior vena cava was cannulated for administration of rANP and other substances. The trachea was also cannulated. The body temperature was maintained by a heating pad.
The efferent discharges were recorded from nerve filaments isolated from the centrally cut end of the renal, adrenal and splenic branch of the splanchnic nerve, and also that of the gastric, pancreatic and hepatic branch of the vagus nerve, respectively (Fig.  1) . A binocular dissection microscope was used for isolation of the filaments. After dissection, the nerve filament was placed on a pair of silver wire recording electrodes and immersed in a mixture of liquid paraffin and vaseline. Efferent nerve activity was amplified by means of a condenser-coupled differential amplifier and fed into a window discriminator which distinguishes nerve discharges from background noise. The numbers of impulses per 5 sec were integrated by a rate meter and displayed on a pen recorder. Electrocardiograph was monitored throughout the experiments.
RESULTS AND DISCUSSION
The rANP 10pg, 100pg, 1ng and 10ng were dissolved in 0.1 ml saline before use, and administrated intravenously. Figure 1 shows typical examples of the effect of rANP on the efferent activities of the visceral sympathetic nerves and vagal nerves.
The upper trace shows the effect on the efferent discharge rate of the renal sympathetic nerve filament. As shown in the trace, an injection of 100pg of rANP caused a slight suppression, that of 1ng a The effect of ANP administrations on the efferent discharge rate of the renal sympathetic nerve and vagal gastric nerve.
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little stronger one, and that of 10ng resulted in a very strong suppression without recovery until the end of observation about 50min after 10ng injection, respectively.
The lower trace shows the effect of intravenous administrations of 10pg, 100 pg and 1ng. An administration of 100pg rANP showed a slight and temporary suppression, and that of 1ng resulted in a strong and long lasting suppression in the discharge rate. However, no change in efferent activity was observed after administration of 10pg rANP. As shown in Table 1 , 10pg administrations were without effect on the efferent discharge rate of sympathetic adrenal nerve (one observation) and that of vagal gastric nerve (one observation).
The administration of 100pg rANP caused slight suppressions in 8 observations out of 15 (total observations on sympathetic and vagal efferents altogether). The application of 1ng rANP resulted in the suppression of efferent discharges in all of the observations (14/15: clear suppression and 1/15: a slight suppression).
In the decerebrated rat (intercollicular level), intravenous administration of 1 ng rANP caused no change in the discharge rate of renal sympathetic efferents or in adrenal sympathetic efferents.
Although the number of observations on vagal efferents was hardly extensive, as a preliminary report the results of experiments will be summarized as follows:
1. Intravenous administration of rANP causes a suppression in the rate of efferent discharges of visceral sympathetic nerves as well as visceral vagal nerves.
2. The critical dose to cause suppression in efferent nervous activity was 100pg, and 1ng administration resulted in a clear suppression in almost all preparations. As the concentration of ANP in the blood plasma is about 100 pg/ml or slightly less (MATSUO, H., personal communhcation), the above described data would be reasonable.
3. In the decerebrated rat, intravenous administrations of rANP were without effect on the efferent activity. The observations suggest that the ANP released from the atrial region into the circulating blood may modulate autonomic outflows and cause an inhibition in the ensuing efferent activity, through the ANP-receptive neurons in the hypothalamic surroundings with insufficient blood brain barrier such as the subfornical organ (SF0) and anteroventral third ventricle region (AV3V) (Fig. 3) .
In relation to this suggestion, OKUYA and YAMA - SHITA (1987) have recently reported the existence of ANP-receptive neurons in the AV3V and parvocellular paraventricular nucleus (PVN) by means of an electrophysiological technique applied to slice preparations. They observed only an inhibitory effect on the neurons in these areas following the application of ANP.
They explained that blood-borne ANP is believed to affect the neurons in the AV3V, especially in the organum vasculosum of the lamina terminalis. There is electrophysiological evidence supporting the view that cells in the PVN project directly to preganglionic cell groups of both parasympathetic (KANNAN and YAMASHITA, 1985) and sympathetic (YAMASHITA, INENAGA and KOIZUMI, 1984) divisions of the autonomic nervous system. It is plauisible that elements in the AV3V detect the information on the ANP in the circulating blood and send that to the autonomic nuclei to modulate the autonomic outflows. It was further reported by HATTORI et al. (1988) that some neurons in the subf ornical organ (SAO) in the hypothalamus, which also lacks a blood-brain barrier, were suppressed by ANP. These neurons may also play some role in tramsmitting information on blood-borne ANP to autonomic centers. Biochem. Biophys. Res. Commun. 117: 859-865 (1983) .
